Why the study?
Does a single oral dose of calcium channel blockers (diltiazem, nifedipine, verapamil) reduce platelet aggregation and alter prostaglandin system parameters in patients with coronary artery disease?
Population
24 patients with coronary artery disease
Follow-up
90 minutes
Authors
Loading...
May suggest antiplatelet effects of diltiazem in CAD; hypothesis-generating and should not yet change practice.
Does a single oral dose of calcium channel blockers (diltiazem, nifedipine, verapamil) reduce platelet aggregation and alter prostaglandin system parameters in patients with coronary artery disease?
A single oral dose of calcium channel blockers, particularly diltiazem, significantly decreases ex vivo platelet function parameters in patients with coronary artery disease.
Weiss et al. (1991) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: